Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Jacquelyn O. Wolff et al.|Blood|2022Cited by 49
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or AsciminibElias Jabbour, H. Kantarjian, Anna Turkina et al.|JAMA Oncology|2024Cited by 26
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Partow Kebriaei, Gabriela Rondón et al.|Transplantation and Cellular Therapy|2024Cited by 6